Derrell Porter's Net Worth
$1.08 Million
Who is Derrell Porter?
Derrell Porter has an estimated net worth of $1.08 Million. This is based on reported shares across multiple companies, which include Atara Biotherapeutics, Inc., Passage BIO, Inc., and Acumen Pharmaceuticals, Inc..
SEC CIK
Derrell Porter's CIK is 0001706400
Past Insider Trading and Trends
2018 was Derrell Porter's most active year for acquiring shares with 3 total transactions. Derrell Porter's most active month to acquire stocks was the month of April. 2019 was Derrell Porter's most active year for disposing of shares, totalling 4 transactions. Derrell Porter's most active month to dispose stocks was the month of January. 2018 saw Derrell Porter paying a total of $233,576.20 for 53,834 shares, this is the most they've acquired in one year. In 2018 Derrell Porter cashed out on 34,212 shares for a total of $797,348.28, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Atara Biotherapeutics, Inc. (ATRA) Snapshot price: $9.1465
SVP, Head Global Commercial
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +46.11% | 10K |
—
|
—
| 31.69K |
Mar 26
| |||
Form 4
| -8.09% | -1.91K |
$27.15 | -$179,160.00 | 21.69K |
Scheduled
|
Feb 15
| ||
Form 4
| -108.23% | -13.53K |
$38.47 | -$46,779.52 | 23.6K |
Feb 6
| |||
Form 4
|
—
|
0
|
$29.66 | -$501,780.48 | 12.5K |
Scheduled
|
May 15
| ||
Form 4
| -10.99% | -1.54K |
$40.15 | -$61,991.60 | 12.5K |
Scheduled
|
May 8
| ||
Form 4
| +809.59% | 12.5K |
—
|
—
| 14.04K |
Feb 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Passage BIO, Inc. (PASG) Snapshot price: $0.7
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Acumen Pharmaceuticals, Inc. (ABOS) Snapshot price: $2.18
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |